APRE
Aprea Therapeutics, Inc. Common stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.67
$-0.00
(-0.49%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $4.69M | EPS (ttm) | $-2.12 | Current Price | $0.67 |
| Enterprise Value | $-8.76M | Forward EPS | $-0.74 | Previous Close | $0.67 |
| P/E Ratio | - | ROA | -41.90% | 52W High | $4.65 |
| Forward P/E | -0.90 | ROE | -74.72% | 52W Low | $0.55 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.94 |
| P/S Ratio | 9.60 | Operating Margin | -168689.83% | 200 Day Avg | $1.44 |
| P/B Ratio | 0.37 | Profit Margin | - | Volume | 433.32K |
| EV/EBITDA | 0.64 | Current Ratio | 5.20 | Avg Volume | 2.02M |
| EV/Sales | -17.95 | Quick Ratio | 5.12 | Beta | 1.61 |
| Employees | 8.00 | Debt/Equity | - | Shares Outstanding | 6.99M |
| Sector | Healthcare | Total Debt | - | Float Shares | 4.49M |
| Industry | Biotechnology | Total Cash | $13.72M | Short Float | 0.57% |
| Optionable | - | Cash/Share | $2.17 | Short Ratio | 0.53 |
| Dividend Yield | - | Book Value/Share | $1.82 | % Held by Insiders | 19.62% |
| Target Price | $6.67 | Revenue (TTM) | $488.24K | % Held by Institutions | 21.60% |